In this current meta-analysis was based on 97 case-control study, with 80361 cases and 78712 control from sixteen countries, thus, this meta-analysis provides the most up-to-date epidemiological evidence supporting IL-6 promoter polymorphisms were significantly associated with the susceptibility and prognosis of cancer. This evidence concerns the gene IL6 and cancer.